EDM-DEDM and protein crystal structure solution

Acta Crystallographica Section D: Biological Crystallography

Volumn 65, Issue 5, 2009, Pages 477-484

  Caliandro, Rocco ^a   Carrozzini, Benedetta ^a   Cascarano, Giovanni Luca ^a   Giacovazzo, Carmelo ^a   Mazzone, Anna Maria ^a   Siliqi, Dritan ^a  

^a CNR   (Italy)

Author keywords

EDM DEDM; Model building; Molecular replacement; Phase refinement

Indexed keywords

ALGORITHM; ARTICLE; CHEMICAL MODEL; CHEMICAL STRUCTURE; COMPUTER PROGRAM; CRYSTALLIZATION; ELECTRON; METHODOLOGY; PROBABILITY; PROTEIN CONFORMATION; STATISTICS; X RAY CRYSTALLOGRAPHY;

ALGORITHMS; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; ELECTRONS; MODELS, CHEMICAL; MODELS, MOLECULAR; PROBABILITY; PROTEIN CONFORMATION; SOFTWARE;

EID: 65349187156     PISSN: 09074449     EISSN: 13990047     Source Type: Journal    
DOI: 10.1107/S0907444909008609     Document Type: Article

References (107)

1. Abrahams, J. P. (1997). Acta Cryst. D53, 371-376.
2. Abrahams, J. P. & Leslie, A. G. W. (1996). Acta Cryst. D52, 30-42.
3. Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C, Sauter, N. K. & Terwilliger, T. C. (2002). Acta Cryst. D58, 1948-1954.
4. Alterio, V, Vitale, R. M., Monti, S. M., Pedone, C, Scozzafava, A., Cecchi, A., De Simone, G. & Supuran, C. T. (2006). J Am. Chem Soc. 128, 8329-8335.
5. Anand, K., Palm, G J., Mesters, J. R., Siddell, S. G, Ziebuhr, J. & Hilgenfeld, R. (2002). EMBO J. 21, 3213-3224.
6. Berman, H., Henrick, K., Nakamura, H. & Markley, J. L. (2007). Nucleic Acids Res. 35, D301-D303.
7. Betzel, G, Dauter, Z., Dauter, M., Ingelman, M., Papendorf, G, Wilson, K. S. & Branner, S. (1988). J Mol. Biol. 204, 803-804.
8. Bradley, P, Misura, K. M. & Baker, D. (2005). Science, 309, 1868- 1871.
9. Burla, M. C, Caliandro, R., Camalli, M., Carrozzini, B., Cascarano, G L., De Caro, L., Giacovazzo, C, Polidori, G, Siliqi, D. & Spagna, R. (2007).J. Appl. Cryst. 40, 609-613.
10. Caliandro, R., Carrozzini, B., Cascarano, G L., De Caro, L., Giacovazzo, C, Mazzone, A. M. & Siliqi, D (2006).J. Appl. Cryst. 39, 185-193.
11. Caliandro, R., Carrozzini, B., Cascarano, G L., De Caro, L., Giacovazzo, C, Mazzone, A. & Siliqi, D (2008).J. Appl. Cryst. 41, 548-553.
12. Caliandro, R., Carrozzini, B., Cascarano, G L., De Caro, L., Giacovazzo, C. & Siliqi, D (2008). Acta Cryst. A64, 519-528.
13. Caliandro, R., Carrozzini, B., Cascarano, G L., Giacovazzo, C, Mazzone, A. M. & Siliqi, D (2009). Acta Cryst. D65, 249-256.
14. Chang, G & Lewis, M. (1997). Acta Cryst. D53, 279-289.
15. Cowtan, K. (1999). Acta Cryst. D55, 1555-1567.
16. Cowtan, K. (2006). Acta Cryst., D62, 1002-1011.
17. Dobbs, A. J., Anderson, B. E, Faber, H. R. & Baker, E. N. (1996). Acta Cryst. D52, 356-368.
18. Dunbrack, R. L. Jr & Cohen, E E. (1997). Protein Sci. 6, 1661-1681.
19. Emsley, P. & Cowtan, K. (2004). Acta Cryst. D60, 2126-2132.
20. Giacovazzo, C. & Siliqi, D (1997). Acta Cryst. A53, 789-798.
21. Glykos, N. M. & Kokkinidis, M. (2000). Acta Cryst. D56, 169-174.
22. Greenblatt, H. M., Feinberg, H., Tucker, P. A. & Shoham, G (1998). Acta Cryst. D54, 289-305.
23. He, Y., Yao, D.-Q., Gu, Y.-J., Lin, Z.-J, Zheng, C.-D. & Fan, H.-F (2007). Acta Cryst. D63, 793-799.
24. Horvath, A. J., Irving, J. A., Rossjohn, J., Law, R. H., Bottomley, S. P, Quinsey, N. S., Pike, R. N., Coughlin, P. B. & Whisstock, J. C. (2005). J. Biol. Chem. 280, 43168-43178.
25. Jamrog, D C, Zhang, Y & Phillips, G N. (2003). Acta Cryst. D59, 304-314.
26. Jones, D T. (1999).J. Mol. Biol. 292,195-202.
27. Kissinger, C. R., Gehlhaar, D K. & Fogel, D B. (1999). Acta Cryst. D55, 484-491.
28. Kolberg, M., Logan, D T., Bleifuss, G, Potsch, S., Sjoberg, B. M., Graslund, A., Lubitz, W, Lassmann, G & Lendzian, F (2005). J Biol. Chem. 280, 11233-11246.
29. Kortemme, T., Joachimiak, L. A., Bullock, A. N., Schuler, A. D, Stoddard, B. L. & Baker, D (2004). Nature Struct. Mol. Biol. 11, 371-379.
30. Levitt, D G (2001). Acta Cryst. D57, 1013-1019.
31. McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D, Winn, M. D, Storoni, L. C. & Read, R. J. (2007).J. Appl. Cryst. 40, 658-674.
32. Navaza, J. (1994). Acta Cryst. A50, 157-163.
33. Perrakis, A., Morris, R. & Lamzin, V. S. (1999). Nature Struct. Biol. 6, 458-463.
34. Qian, B., Raman, S., Das, R., Bradley, P., McCoy, A. J., Read, R. J. & Baker, D. (2007). Nature (London), 450, 259-264.
35. Read, R. J. (2001). Acta Cryst. D57, 1373-1382.
36. Refaat, L. S. & Woolfson, M. M. (1993). Acta Cryst. D49, 367-371.
37. Rigden, D. J., Keegan, R. M. & Wimi, M. D. (2008). Acta Cryst. D64, 1288-1291.
38. Sali, A. & Blundell, T. L. (1993). J Mol. Biol. 234,779-815.
39. Schwarzenbacher, R., Godzik, A., Grzechnik, S. K. & Jaroszewski, L. (2004). Acta Cryst. D60, 1229-1236.
40. Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
41. Sheriff, S., Klei, H. E. & Davis, M. E. (1999). J Appl. Cryst. 32, 98-101.
42. Shortle, D, Simons, K. T. & Baker, D (1998). Proc. Natl Acad. Sci USA, 95, 11158-11162.
43. Simons, K. T., Kooperberg, G, Huang, E. & Baker, D (1997).J. Mol Biol. 268, 209-225.
44. Simons, K. T., Ruczinski, I., Kooperberg, C, Fox, B. A., Bystroff, C. & Baker, D (1999). Proteins, 34, 82-95.
45. Terwilliger, T. C. (2003a). Acta Cryst. D59, 38-44.
46. Terwilliger, T. C. (2003b). Acta Cryst. D59, 1174-1182.
47. Terwilliger, T. C. (2004).J. Synchrotron Rad. 11, 49-52.
48. Terwilliger, T C, Grosse-Kunstleve, R. W., Afonine, P. V., Moriarty, N. W., Zwart, P. H, Hung, L.-W., Read, R. J. & Adams, P. D (2008). Acta Cryst. D64, 61-69.
49. Turk, D (1992). PhD thesis. Technische Universitat München, Germany.
50. Uhrinova, S., Uhrin, D, Nairn, J., Price, N. C, Fothergill-Gilmore, L. A. & Barlow, P. N. (2001).J. Mol. Biol. 306, 275-290.
51. Vagin, A. & Teplyakov, A. (1997).J. Appl. Cryst. 30, 1022-1025.
52. Ju, H. & Hauptman, H. A. (2006). Acta Cryst. D62, 897-900.
53. Yao, J.-X. (1981). Acta Cryst. A37, 642-644.
54. Yao, J.-X. (2002). Acta Cryst. D58, 1941-1947.
55. Zhang, K. Y J., Cowtan, K. D & Main, P. (2001). International Tables for Crystallography, Vol. F, edited by E. Arnold & M. G Rossmann, pp. 311-331. Dordrecht: Kluwer Academic Publishers.
56. Zhang, T, He, Y, Gu, Y.-X., Zheng, C.-D, Hao, Q., Wang, J.-W. & Fan, H.-E (2007). OAS1S06: A Direct-Method Program for SAD/ SIR Phasing and Reciprocal-Space Fragment Extension. Institute of Physics, Chinese Academy of Sciences, Beijing, People's Republic of China.
57. von Itzstein, M.; Dyason, J. C; Oliver, S. W.; White, H. F.; Wu, W. Y.; Kok, G. B.; Pegg, M. S. A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs. J. Med. Chem. 1996, 39, 388-391.
58. White, C. L.; Janakiraman, M. N.; Laver, W. G.; Philippon, C; Vasella, A.; Air, G. M.; Luo, M. A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies. J. Mol. Biol. 1995 245, 623-634.
59. White, C. L.; Janakiraman, M. N.; Laver, W. G.; Philippon, C; Vasella, A.; Air, G. M.; Luo, M. A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies. J. Mol. Biol. 1995 245, 623-634.
60. Taylor, N. R.; von Itzstein, M. Molecular Modeling Studies on Ligand Binding to Sialidase from Influenza Virus and the Mechanism of Catalysis. J. Med. Chem. 1994, 37, 616-624.
61. Stoll, V.; Stewart, K. D.; Marmg, C. J.; Muchmore, S.; Giranda, V.; Gu, Y. G.; Wang, G.; Chen, Y.; Sun, M.; Zhao, C; Kennedy, A. L.; Madigan, D. L.;
62. Xu, Y.; Saldivar, A.; Kati, W.; Laver, G.; Sowin, T.; Sham, H. L.; Greer, J.; Kempf, D. Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series. Biochemistry 2003, 42, 718-727.
63. Jedrzejas, M. J.; Singh, S.; Brouillette, W. J.; Laver, W. G.; Air, G. M.; Luo, M. Structures of aromatic inhibitors of influenza virus neuraminidase. Biochemistry 1995, 34, 3144-3151.
64. Jedrzejas, M. J.; Singh, S.; Brouillette, W. J.; Laver, W. G.; Air, G. M.; Luo, M. Structures of aromatic inhibitors of influenza virus neuraminidase. Biochemistry 1995, 34, 3144-3151.
65. Jedrzejas, M. J.; Singh, S.; Brouillette, W. J.; Laver, W. G.; Air, G. M.; Luo, M. Structures of aromatic inhibitors of influenza virus neuraminidase. Biochemistry 1995, 34, 3144-3151.
66. Singh, S.; Jedrzejas, M. J.; Air, G. M.; Luo, M.; Laver, W. G.; Brouillette, W. J. Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. J. Med. Chem. 1995 58,3217-3225.
67. Varghese, J. N.; Smith, P. W.; Solhs, S. L.; Bhck, T. J.; Sahasrabudhe, A.; McKimm-Breschkm, J. L.; Colman, P. M. Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. Structure 1998, 6, 735-746.
68. Varghese, J. N.; Smith, P. W.; Solhs, S. L.; Bhck, T. J.; Sahasrabudhe, A.; McKimm-Breschkm, J. L.; Colman, P. M. Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. Structure 1998, 6, 735-746.
69. White, C. L.; Janakiraman, M. N.; Laver, W. G.; Philippon, C; Vasella, A.; Air, G. M.; Luo, M. A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies. J. Mol. Biol. 1995 245, 623-634.
70. Mann, M. C; Islam, T.; Dyason, J. C; Florio, P.; Trower, C. J.; Thomson, R. J.; von Itzstein, M. Unsaturated N-acetyl- D-glucosaminuronic acid glycosides as inhibitors of influenza virus sialidase. Glycoconj. J. 2006 23, 127-133.
71. McKimm-Breschkm, J.L.; Sahasrabudhe, A.; Bhck, T.J.; McDonald, M.; Colman, P. M.; Hart, G. J.; Bethell, R. C; Varghese, J. N. Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors. J. Vir. 1998, 72, 2456-2462.
72. McKimm-Breschkm, J.L.; Sahasrabudhe, A.; Bhck, T.J.; McDonald, M.; Colman, P. M.; Hart, G. J.; Bethell, R. C; Varghese, J. N. Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors. J. Vir. 1998, 72, 2456-2462.
73. McKimm-Breschkm, J.L.; Sahasrabudhe, A.; Bhck, T.J.; McDonald, M.; Colman, P. M.; Hart, G. J.; Bethell, R. C; Varghese, J. N. Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors. J. Vir. 1998, 72, 2456-2462.
74. Smith, B. J.; Colman, P. M.; von Itzstein, M.; Danylec, B.; Varghese, J. N. Analysis of inhibitor binding in influenza virus neuraminidase. Protein. Sci. 2001, 10, 689-696.
75. Smith, P. W.; Solhs, S. L.; Howes, P. D; Cherry, P. C; Cobley, K. N.; Taylor, H.; Whittmgton, A. R.; Scicinski, J.; Bethell, R. C; Taylor, N.; Skarzynski, T.; Cleasby, A.; Singh, O.; Wonacott, A.; Varghese, J.; Colman, P. Novel inhibitors of influenza sialidases related to GG167 structure-activity, crystallographic and Molecular dynamics studies with 4H-pyran-2-carboxylic acid 6-carboxamides. Bioorg.Med. Chem. Lett. 1996, 6, 2931-2936.
76. McKimm-Breschkm, J.L.; Sahasrabudhe, A.; Bhck, T.J.; McDonald, M.; Colman, P. M.; Hart, G. J.; Bethell, R. C; Varghese, J. N. Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors. J. Vir. 1998, 72, 2456-2462.
77. Smith, B. J.; Colman, P. M.; von Itzstein, M.; Danylec, B.; Varghese, J. N. Analysis of inhibitor binding in influenza virus neuraminidase. Protein. Sci. 2001, 10, 689-696.
78. Smith, B. J.; Colman, P. M.; von Itzstein, M.; Danylec, B.; Varghese, J. N. Analysis of inhibitor binding in influenza virus neuraminidase. Protein. Sci. 2001, 10, 689-696.
79. McKimm-Breschkin, J.L.; Sahasrabudhe, A.; Blick, T.J.; McDonald, M.; Colman, P. M.; Hart, G. J.; Bethell, R. C; Varghese, J. N. Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors. J. Vir. 1998, 72, 2456-2462.
80. Kati, W. M.; Montgomery, D.; Carrick, R.; Gubareva, L.; Maring, C; McDaniel, K.; Steffy, K.; Molla, A.; Hayden, F.; Kempf, D.; Kohlbrenner, W. In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication. Antimicrob. Agents Chemother. 2002, 46, 1014-1021.
81. McKimm-Breschkm, J.L.; Sahasrabudhe, A.; Blick, T.J.; McDonald, M.; Colman, P. M.; Hart, G. J.; Bethell, R. C; Varghese, J. N. Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors. J. Vir. 1998, 72, 2456-2462.
82. McKimm-Breschkm, J.L.; Sahasrabudhe, A.; Blick, T.J.; McDonald, M.; Colman, P. M.; Hart, G. J.; Bethell, R. C; Varghese, J. N. Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors. J. Vir. 1998, 72, 2456-2462.
83. McKimm-Breschkm, J.L.; Sahasrabudhe, A.; Blick, T.J.; McDonald, M.; Colman, P. M.; Hart, G. J.; Bethell, R. C; Varghese, J. N. Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors. J. Vir. 1998, 72, 2456-2462.
84. Varghese, J. N.; Smith, P. W.; Solhs, S. L.; Blick, T. J.; Sahasrabudhe, A.; McKimm-Breschkm, J. L.; Colman, P. M. Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. Structure 1998, 6, 735-746.
85. Varghese, J. N.; Smith, P. W.; Solhs, S. L.; Blick, T. J.; Sahasrabudhe, A.; McKimm-Breschkm, J. L.; Colman, P. M. Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. Structure 1998, 6, 735-746.
86. Yen, H. L.; Herlocher, L. M.; Hoffmann, E.; Matrosovich, M. N.; Monto, A. S.; Webster, R. G.; Govorkova, E. A. Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrob. Agents Chemother. 2005, 49, 4075-4084.
87. Varghese, J. N.; Smith, P. W.; Solhs, S. L.; Blick, T. J.; Sahasrabudhe, A.; McKimm-Breschkm, J. L.; Colman, P. M. Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. Structure 1998, 6, 735-746.
88. Kati, W. M.; Montgomery, D.; Carrick, R.; Gubareva, L.; Maring, C; McDaniel, K.; Steffy, K.; Molla, A.; Hayden, F.; Kempf, D.; Kohlbrenner, W. In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication. Antimicrob. Agents Chemother. 2002, 46, 1014-1021.
89. Varghese, J. N.; Smith, P. W.; Solhs, S. L.; Blick, T. J.; Sahasrabudhe, A.; McKimm-Breschkm, J. L.; Colman, P. M. Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. Structure 1998, 6, 735-746.
90. Yen, H. L.; Herlocher, L. M.; Hoffmann, E.; Matrosovich, M. N.; Monto, A. S.; Webster, R. G.; Govorkova, E. A. Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrob. Agents Chemother. 2005, 49, 4075-4084.
91. Kati, W. M.; Montgomery, D.; Carrick, R.; Gubareva, L.; Maring, C; McDaniel, K.; Steffy, K.; Molla, A.; Hayden, F.; Kempf, D.; Kohlbrenner, W. In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication. Antimicrob. Agents Chemother. 2002, 46, 1014-1021.
92. Maring, C. J.; Stoll, V. S.; Zhao, C; Sun, M.; Krueger, A. C; Stewart, K. D.; Madigan, D. L.; Kati, W. M.; Ju, Y.; Carrick, R. J.; Montgomery, D. A.; Kempf-Grote, A.; Marsh, K. C; Molla, A.; Steffy, K. R.; Sham, H. L.; Laver, W. G.; Gu, Y. G.; Kempf, D. J.; Kohlbrenner, W. E. Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitors. J. Med. Chem. 2005, 48, 3980-3990.
93. Stall, V.; Stewart, K. D.; Marmg, C. J.; Muchmore, S.; Giranda, V.; Gu, Y. G.; Wang, G.; Chen, Y.; Sun, M.; Zhao, C; Kennedy, A. L.; Madigan, D. L.; Xu, Y.; Saldivar, A.; Kati, W.; Laver, G.; Sowin, T.; Sham, H. L.; Greer, J.; Kempf, D. Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series. Biochemistry 2003, 42, 718-727.
94. Wang, G. T.; Wang, S.; Gentles, R.; Sowin, T.; Marmg, C. J.; Kempf, D. J.; Kati, W. M.; Stall, V.; Stewart, K. D.; Laver, G. Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core. Bioorg. Med. Chem. Lett. 2005,15, 125-128.
95. Wang, G. T.; Wang, S.; Gentles, R.; Sowin, T.; Marmg, C. J.; Kempf, D. J.; Kati, W. M.; Stall, V.; Stewart, K. D.; Laver, G. Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core. Bioorg. Med. Chem. Lett. 2005,15, 125-128.
96. Jedrzejas, M. J.; Singh, S.; Brouillette, W. J.; Laver, W. G.; Air, G. M.; Luo, M. Structures of aromatic inhibitors of influenza virus neuraminidase. Biochemistry 1995, 34, 3144-3151.
97. Taylor, N. R.; Cleasby, A.; Singh, O.; Skarzynski, T.; Wonacott, A. J.; Smith, P. W.; Solhs, S. L; Howes, P. D.; Cherry, P. C; Bethell, R.; Colman, P.; Varghese, J. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B. J. Med. Chem. 1998, 41, 798-807.
98. White, C. L.; Janakiraman, M. N.; Laver, W. G.; Philippon, C; Vasella, A.; Air, G. M.; Luo, M. A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies. J. Mol. Biol. 1995 245, 623-634.
99. Smith, P. W.; Solhs, S. L.; Howes, P. D.; Cherry, P. C; Starkey, I. D.; Cobley, K. N.; Weston, H.; Scicinski, J.; Merritt, A.; Whittington, A.; Wyatt, P.; Taylor, N.; Green, D.; Bethell, R.; Madar, S.; Fenton, R. J.; Morley, P. J.; Pateman, T.; Beresford, A. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides. J. Med. Chem. 1998, 41, 787-797.
100. Jedrzejas, M. J.; Singh, S.; Brouillette, W. J.; Laver, W. G.; Air, G. M.; Luo, M. Structures of aromatic inhibitors of influenza virus neuraminidase. Biochemistry 1995, 34, 3144-3151.
101. Fmley, J. B.; Atigadda, V. R.; Duarte, F.; Zhao, J. J.; Brouillette, W. J.; Air, G. M.; Luo, M. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site. J. Mol. Biol. 1999, 293, 1107-1119.
102. Atigadda, V. R.; Brouillette, W. J.; Duarte, F.; Babu, Y. S.; Bantia, S.; Chand, P.; Chu, N.; Montgomery, J. A.; Walsh, D. A.; Sudbeck, E.; Finley, J.; Air, G. M.; Luo, M.; Laver, G. W. Hydrophobic benzoic acids as inhibitors of influenza neuraminidase. Bioorg. Med. Chem. 1999, 7, 2487-2497.
103. Lommer, B. S.; Ali, S. M.; Bajpai, S. N.; Brouillette, W. J. ; Air, G. M.; Luo, M. A benzoic acid inhibitor induces a novel conformational change in the active site of Influenza B virus neuraminidase Acta Crystallogr. 2004, D60, 1017-1023.
104. Lommer, B. S.; Ali, S. M.; Bajpai, S. N.; Brouillette, W. J. ; Air, G. M.; Luo, M. A benzoic acid inhibitor induces a novel conformational change in the active site of Influenza B virus neuraminidase Acta Crystallogr. 2004, D60, 1017-1023.
105. Finley, J. B.; Atigadda, V. R; Duarte, F.; Zhao, J. J.; Brouillette, W. J.; Air, G. M.; Luo, M. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site. J. Mol. Biol. 1999, 293, 1107-1119.
106. Atigadda, V. R.; Brouillette, W. J.; Duarte, F.; Ali, S. M.; Babu, Y. S.; Bantia, S.; Chand, P.; Chu, N; Montgomery, J. A.; Walsh, D. A.; Sudbeck, E. A.; Finley, J.; Luo, M.; Air, G. M.; Laver, G. W. Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent. J. Med. Chem. 1999, 42, 2332-2343.
107. Finley, J. B.; Atigadda, V. R.; Duarte, F.; Zhao, J. J.; Bromllette, W. J.; Air, G. M.; Luo, M. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site. J. Mol. Biol. 1999, 293, 1107-1119.